Shenzhen British Maisi culture Technology Co., Ltd
has powerful R&D team formed by PhDs and MS, who has NMR, ICP-MS,
and LC-MS. The team shares value of science, demonstration, diligent and
harmony, and working on the research of production quality in the
production process of Techdow was researched and developed
independently. Techdow owns several proprietary intellectual property
rights. The products have been structure confirmed strictly by
self-develop RPIP-UPLC-MS, RPIP-UPLC-MS, UPLC-SEC-MS. Techdow has
become the only manufacturer passed EU quality review and approved
generic enoxaparin sodium injection in EU markets.
Techdow pays attention to IPR. At present, Techdow has achieved 7 patents of invention. And more products are being R&D.
The R&D team has rich experiences of developing sterilized injection to offer excellent service of developing externally.